Literature DB >> 3215691

HIV-IgM serology.

G Bedarida, P Crocchiolo, G Cambié, F D'Agostino, C Uberti Foppa, E Berto, M E Grisi, I Arcidiacono, M G Ronsivalle, M Pasquali.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3215691     DOI： 10.1007/bf01645079

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  4 in total

1.  HIV IgM antibodies in risk groups who are seronegative on ELISA testing.

Authors:  G Bedarida; G Cambiè; F D'Agostino; M G Ronsivalle; E Berto; M E Grisi
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

2.  Antibody response to human immunodeficiency virus after primary infection.

Authors:  D A Cooper; A A Imrie; R Penny
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

3.  Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection.

Authors:  A Ranki; S L Valle; M Krohn; J Antonen; J P Allain; M Leuther; G Franchini; K Krohn
Journal:  Lancet       Date:  1987-09-12       Impact factor: 79.321

4.  Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection.

Authors:  J Goudsmit; F de Wolf; D A Paul; L G Epstein; J M Lange; W J Krone; H Speelman; E C Wolters; J Van der Noordaa; J M Oleske
Journal:  Lancet       Date:  1986-07-26       Impact factor: 79.321
  4 in total
  1 in total

1.  New sensitive and specific assay for human immunodeficiency virus antibodies using labeled recombinant fusion protein and time-resolved fluoroimmunoassay.

Authors:  H Siitari; P Turunen; J Schrimsher; M Nunn
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.